Concepedia
Statistics
Publications
26
Citations
3.1K
H-Index
22
Active since
1997
Affiliations
Amgen (United States)(Current)
Amgen (Canada)
University of British Columbia
AstraZeneca (United Kingdom)
Arbutus Biopharma (Canada)
Ian N. Foltz is an author at Amgen (United States) specializing in life sciences, cell signaling, and immunology.
Publications per year
1997–2021
Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody
Ross Stewart, Michelle Morrow, Scott A. Hammond et al. · Cancer Immunology Research · 2015 · 409 citations
Life Sciences, Immunology, Oncology +17
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects
Kannan Gunasekaran, Martin Pentony, Min Shen et al. · Journal of Biological Chemistry · 2010 · 284 citations · Full text
Pharmacy, Biotechnology, Immunology +17
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
Elizabeth A. Killion, Jinghong Wang, Junming Yie et al. · Science Translational Medicine · 2018 · 224 citations · Full text
Medicine, Endocrinology, Pharmacology +17
Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex
Ian N. Foltz, Sylvia Hu, Chadwick King et al. · Science Translational Medicine · 2012 · 211 citations
Life Sciences, Biochemistry, Endocrinology +14
Hemopoietic Growth Factors with the Exception of Interleukin-4 Activate the p38 Mitogen-activated Protein Kinase Pathway
Ian N. Foltz, John C. Lee, Peter R. Young et al. · Journal of Biological Chemistry · 1997 · 173 citations · Full text
Life Sciences, Cell Biology, Immunology +15
1–5 of 26